Live Breaking News & Updates on ரியான் பால்க்க் ஜோன்ஸ்

Stay updated with breaking news from ரியான் பால்க்க் ஜோன்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Myeloid immune cells in blood tied to severe COVID-19


Date Time
Myeloid immune cells in blood tied to severe COVID-19
Individual variations in how the immune system responds to SARS-CoV-2 appear to impact the severity of disease. Researchers at Karolinska Institutet have now been able to show that patients with severe COVID-19 have significantly elevated levels of a certain type of immune cells in their blood, called myeloid-derived suppressor cells. The study published in the Journal of Clinical Investigation may bring an increased understanding of how early immune responses impact disease severity.
Anna Smed Sörensen. Photo: Ulf Sirborn.
Most individuals with COVID-19 develop mild to moderate symptoms and recover without needing hospital treatment. In severe cases, however, COVID-19 can lead to respiratory failure or even death. It is not yet known why the severity of disease varies so much between patients. ....

United States , Meng Yu , Holden Maecker , Inga Szurgot , Sindhu Vangeti , Isabella Badolati , Jan Albert , Max Bell , Karolinska Institutet , Niclas Johansson , Alberto Cagigi , Maximilian Julius Lautenbach , Ryan Falck Jones , Ulf Sirborn , Klara Lenart , Fang Lin , Sara Falck Jones , Alice Wallenberg Foundation , Melinda Gates Foundation , Lung Foundation , Swedish Research Council , Karolinska University Hospital , Department Of Medicine , Stanford University , Clinical Investigation , Stemirna Therapeutics ,

Myeloid immune cells in the blood tied to severe COVID-19


 E-Mail
Credit: Ulf Sirborn
Individual variations in how the immune system responds to SARS-CoV-2 appear to impact the severity of disease. Researchers at Karolinska Institutet in Sweden have now been able to show that patients with severe COVID-19 have significantly elevated levels of a certain type of immune cells in their blood, called myeloid-derived suppressor cells. The study published in the
Journal of Clinical Investigation may bring an increased understanding of how early immune responses impact disease severity.
Most individuals with COVID-19 develop mild to moderate symptoms and recover without needing hospital treatment. In severe cases, however, COVID-19 can lead to respiratory failure or even death. It is not yet known why the severity of disease varies so much between patients. ....

United States , Meng Yu , Holden Maecker , Inga Szurgot , Jorgen Salde , Sindhu Vangeti , Isabella Badolati , Jan Albert , Eric Ahlberg , Max Bell , Karolinska Institutet , Niclas Johansson , Anna Farnert , Alberto Cagigi , Ryan Falck Jones , Maximilian Julius Lautenbach , Bjorn Osterberg , Klara Lenart , Fang Lin , Sara Falck Jones , Alice Wallenberg Foundation , Melinda Gates Foundation , Lung Foundation , Swedish Research Council , Karolinska University Hospital , Department Of Medicine ,